AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5. A total of 24 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,311,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 77,485,000 | $114,968,000 | 1.57% |
| CSS LLC/IL | 18,230,000 | $27,076,000 | 1.34% |
| BTG Pactual Global Asset Management Ltd | 9,843 | $14,605,000 | 1.28% |
| Castle Creek Arbitrage, LLC | 13,572,000 | $20,145,000 | 0.96% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 43,402,000 | $64,289,000 | 0.92% |
| Pinnacle Holdings, LLC | 1,825,000 | $2,707,753,000 | 0.89% |
| Rhenman & Partners Asset Management AB | 77,000 | $2,648,000 | 0.77% |
| GLAZER CAPITAL, LLC | 3,500,000 | $5,197,000 | 0.75% |
| ANGELO GORDON & CO., L.P. | 9,690,000 | $14,378,000 | 0.70% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 25,700,000 | $38,132,000,000 | 0.66% |